Kevin N. Heller
Signal active
Chief Medical Officer
Bio
Kevin N. Heller is the Chief Medical Officer of Tallac Therapeutics. He previously worked at Jasper Therapeutics as an Executive Vice President Research and Development. Kevin N. Heller attended Yale University.
Location
Washington, District of Columbia, United States, North America
Social
Primary Organization
Tallac Therapeutics
Founded
2018
Employees
11-50
Industry
Biotechnology, Health Care, Therapeutics
Jobs history
2
Tallac Therapeutics
Chief Medical Officer
2023 - Current
NextCure
Chief Medical Officer
2018 - 2021
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Kevin N. Heller is the Chief Medical Officer at Tallac Therapeutics, based in United States, North America. With a background in Biotechnology, Kevin N. Heller has a rich history of leadership and innovation. Kevin N. Heller studied BS Molecular Biophysics and Biochemistry @ Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity